Author
Listed:
- Michel-Elie Bachour
(Department of Medical Oncology, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK)
- Rukhshana Dina Rabbani
(Department of Medical Oncology, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK)
- Mahmudul Rahat Hasan
(Department of Acute Medicine, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK)
- Sumaya Akter
(Department of Medical Oncology, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK)
- Premsai Chilakuluri
(Department of Medical Oncology, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK)
- Soirindhri Banerjee
(Department of Medical Oncology, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK)
- Aruni Ghose
(Department of Medical Oncology, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK
Department of Research and Innovation, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK)
- Elisabet Sanchez
(Department of Medical Oncology, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK)
- Temitayo Ahmadu
(Kent Medway Medical School, University of Kent, Canterbury CT2 7LX, UK)
- Vasileios Papadopoulos
(Department of Urology, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK)
- Jennifer Teke
(Department of Research and Innovation, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK
Faculty of Medicine, Health and Social Care, Canterbury Christ Church University, Canterbury CT1 1QU, UK)
- David Bamidele Olawade
(Department of Research and Innovation, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK)
- Saak Victor Ovsepian
(Faculty of Engineering and Science, University of Greenwich London, Chatham Maritime ME4 4TB, UK
Faculty of Medicine, Tbilisi State University, 0177 Tbilisi, Georgia)
- Stergios Boussios
(Department of Medical Oncology, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK
Department of Research and Innovation, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK
Kent Medway Medical School, University of Kent, Canterbury CT2 7LX, UK
Faculty of Medicine, Health and Social Care, Canterbury Christ Church University, Canterbury CT1 1QU, UK)
Abstract
Metastatic spinal cord compression (MSCC) is a common complication in cancer patients, occurring in 3–5% of diagnosed cases annually, and serves as the initial manifestation of malignancy in 20% of patients. Timely diagnosis and management are critical due to the risk of irreversible neurological damage and the significant impact on both quality and quantity of life. The National Institute for Health and Care Excellence (NICE) recommends that patients presenting with back pain accompanied by neurological signs and/or symptoms undergo whole-spine magnetic resonance imaging (MRI) within 24 h. This retrospective study at Medway Maritime Hospital in England aimed to assess adherence to these guidelines by reviewing the time from presentation to MRI for patients exhibiting symptoms and/or signs of MSCC. Data for 69 patients were collected over one year using electronic patient records and the acute oncology service database. Analysis revealed that MRI was conducted within 24 h in only 43 out of 69 cases (62%), and 16 out of 25 delayed cases (i.e., MRI done beyond the recommended 24 h window) experienced delays of more than 48 h. To improve guideline adherence, interventions such as informational flyers and regular MSCC training sessions, including trainee teaching and presentations during grand rounds, were implemented. A follow-up re-audit involving 113 patients over one year demonstrated improved adherence to the 24 h MRI guideline, with 81 out of 113 cases (71%) meeting the target. The second cycle also documented reasons for delays, identifying patient compliance and pain control as primary factors. Additionally, the timing of steroid administration following suspicion of MSCC was recorded. Future studies should re-assess adherence, focus on better documentation of delay causes, enhance pain management before MRI scans, and ensure prompt steroid administration.
Suggested Citation
Michel-Elie Bachour & Rukhshana Dina Rabbani & Mahmudul Rahat Hasan & Sumaya Akter & Premsai Chilakuluri & Soirindhri Banerjee & Aruni Ghose & Elisabet Sanchez & Temitayo Ahmadu & Vasileios Papadopoul, 2025.
"Spinal MRI in Patients with Suspected Metastatic Spinal Cord Compression: A Quality Improvement Audit in a District General Hospital in Kent, UK,"
IJERPH, MDPI, vol. 22(3), pages 1-11, March.
Handle:
RePEc:gam:jijerp:v:22:y:2025:i:3:p:401-:d:1608847
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:22:y:2025:i:3:p:401-:d:1608847. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.